Scarica l'app Stockscreener
12.57
0.16%
-0.02
Dopo l'orario di chiusura:
12.54
-0.03
-0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Precedente Chiudi:
$12.59
Aprire:
$12.58
Volume 24 ore:
9.30M
Relative Volume:
1.60
Capitalizzazione di mercato:
$8.58B
Reddito:
$125.68M
Utile/perdita netta:
$4.81B
Rapporto P/E:
2.2248
EPS:
5.65
Flusso di cassa netto:
$-781.21M
1 W Prestazione:
+5.28%
1M Prestazione:
+9.21%
6M Prestazione:
+21.80%
1 anno Prestazione:
+6.98%
Intervallo 1D:
$12.53
$13.08
Intervallo di 1 settimana:
$11.85
$13.08
Portata 52W:
$8.73
$13.08
Roivant Sciences Ltd Stock (ROIV) Company Profile
Nome
Roivant Sciences Ltd
Settore
Industria
Telefono
441-295-5950
Indirizzo
7TH FLOOR, 50 BROADWAY, LONDON
Confronta ROIV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
12.57 | 8.46B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2024-01-05 | Iniziato | Piper Sandler | Overweight |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-10-17 | Iniziato | Guggenheim | Buy |
| 2023-06-08 | Iniziato | BofA Securities | Neutral |
| 2022-10-27 | Iniziato | JP Morgan | Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2022-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Iniziato | Goldman | Buy |
| 2021-11-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-28 | Iniziato | Citigroup | Buy |
| 2021-10-26 | Iniziato | Cowen | Outperform |
| 2021-10-26 | Iniziato | Jefferies | Buy |
| 2021-10-26 | Iniziato | Truist | Buy |
Mostra tutto
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Transcript : Roivant Sciences Ltd.Special Call - MarketScreener
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients - GlobeNewswire Inc.
Using RSI to spot recovery in Roivant Sciences Ltd.July 2025 Pullbacks & Free Growth Oriented Trading Recommendations - Newser
Short interest data insights for Roivant Sciences Ltd.July 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
Published on: 2025-09-03 09:05:20 - Newser
Technical analysis overview for Roivant Sciences Ltd. stock2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Is Roivant Sciences Ltd. stock bottoming outJuly 2025 Short Interest & AI Powered Market Entry Ideas - Newser
Real time pattern detection on Roivant Sciences Ltd. stockJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - Newser
Is Roivant Sciences Ltd. forming a reversal patternEarnings Summary Report & AI Driven Stock Movement Reports - Newser
What machine learning models say about Roivant Sciences Ltd.Weekly Stock Summary & Expert Approved Momentum Trade Ideas - Newser
Can swing trading help recover from Roivant Sciences Ltd. losses2025 Key Lessons & Daily Technical Forecast Reports - Newser
Order flow analysis tools used on Roivant Sciences Ltd.2025 Dividend Review & Weekly Top Gainers Alerts - Newser
Will a bounce in Roivant Sciences Ltd. offer an exitJuly 2025 PreEarnings & Weekly High Momentum Picks - Newser
Combining price and volume data for Roivant Sciences Ltd.Trade Analysis Report & Growth Oriented Trade Recommendations - Newser
How institutional ownership impacts Roivant Sciences Ltd. stockJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Roivant Sciences Ltd. stock daily chart insightsJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - Newser
Citi Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $16 - 富途牛牛
Citigroup initiates coverage on Roivant Sciences with Buy rating and $16 price target. - AInvest
How to monitor Roivant Sciences Ltd. with trend dashboardsWeekly Market Report & Capital Efficiency Focused Ideas - Newser
Will Roivant Sciences Ltd. bounce back from current supportEarnings Recap Summary & Daily Entry Point Alerts - Newser
Trading Bots Trigger Alerts on Roivant Sciences Ltd. Activity getLinesFromResByArray error: size == 0 - thegnnews.com
Automated trading signals detected on Roivant Sciences Ltd.Quarterly Growth Report & Low Drawdown Trading Strategies - Newser
How to use Fibonacci retracement on Roivant Sciences Ltd.Portfolio Return Report & Safe Entry Zone Identification - Newser
Analyzing Roivant Sciences Ltd. with risk reward ratio chartsJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - Newser
Chart overlay techniques for tracking Roivant Sciences Ltd.Stop Loss & Verified Stock Trade Ideas - Newser
Building trade automation scripts for Roivant Sciences Ltd.Global Markets & Proven Capital Preservation Tips - Newser
Identifying reversal signals in Roivant Sciences Ltd.July 2025 Fed Impact & AI Driven Price Forecasts - Newser
Forecasting Roivant Sciences Ltd. price range with options data2025 Price Momentum & Daily Market Momentum Tracking - Newser
Can a trend reversal in Roivant Sciences Ltd. lead to recoveryPortfolio Risk Report & Reliable Entry Point Alerts - Newser
Applying Elliott Wave Theory to Roivant Sciences Ltd.July 2025 Trade Ideas & Stock Portfolio Risk Management - Newser
News impact scoring models applied to Roivant Sciences Ltd.Market Trend Summary & Free Weekly Watchlist of Top Performers - Newser
Tools to monitor Roivant Sciences Ltd. recovery probability2025 Investor Takeaways & Daily Price Action Insights - Newser
Is Roivant Sciences Ltd. stock a good hedge against inflationJuly 2025 Opening Moves & Expert Curated Trade Setups - Newser
Roivant Sciences (ROIV) Announces Q1 2025 Business Update - MSN
Will Roivant Sciences Ltd. rebound enough to break evenJuly 2025 PreEarnings & Community Shared Stock Ideas - Newser
How high can Roivant Sciences Ltd. stock goMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Roivant Sciences Ltd Azioni (ROIV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Roivant Sciences Ltd Azioni (ROIV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Venker Eric | President & Immunovant CEO |
Aug 20 '25 |
Sale |
11.72 |
100,000 |
1,172,000 |
1,653,585 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):